• Citer

A meta-analysis of phase III trials evaluating the predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy

par Di Leo, Angelo ;Isola, Jorma;Piette, F;Ejlertsen, Bent;Pritchard, Kathleen;Bartlett, John M S;Desmedt, Christine ;Larsimont, Denis ;Tanner, M;Mouridsen, Henning;O'Malley, Frances P;Twelves, C.;Cardoso, Fatima ;Poole, CJ;Piccart-Gebhart, Martine ;Buyse, Marc
Référence SABCS - San Antonio Breast Cancer Symposium(December 2008: San Antonio, Tx,, USA), Cancer Research Supplement, 2008 SABCS - San Antonio Breast Cancer Symposium, Vol. Vol. 69, Issue 2 (Suppl.)
Publication Publié, 2009-01

Abstract de conférence

• Détails
• Contenu

Titre:	A meta-analysis of phase III trials evaluating the predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy
Auteur:	Di Leo, Angelo; Isola, Jorma; Piette, F; Ejlertsen, Bent; Pritchard, Kathleen; Bartlett, John M S; Desmedt, Christine; Larsimont, Denis; Tanner, M; Mouridsen, Henning; O'Malley, Frances P; Twelves, C.; Cardoso, Fatima; Poole, CJ; Piccart-Gebhart, Martine; Buyse, Marc
Informations sur la publication:	SABCS - San Antonio Breast Cancer Symposium(December 2008: San Antonio, Tx,, USA), Cancer Research Supplement, 2008 SABCS - San Antonio Breast Cancer Symposium, Vol. Vol. 69, Issue 2 (Suppl.)
Statut de publication:	Publié, 2009-01
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais